References
- YangC.YuW.BiY.LongF.LiY.WeiD.HaoX.SituJ.ZhaoY.HuangF.Increased oestradiol in hepatitis E virus-infected pregnant women promotes viral replicationJournal of Viral Hepatitis2018256 742 75110.1111/jvh.12865
- Aslam, A., Susheela, A., Iriana, S., Chan, S. S. & Lau, D. Acute hepatitis E superinfection leading to chronic hepatitis B reactivation. BMJ Case Rep.2018, pii: bcr-2017–223616 (2018).
- Blasco-PerrinHet al.Hepatitis E virus in patients with decompensated chronic liver disease. A prospective UK/French studyAliment. Pharmacol. Ther.20154257458110.1111/apt.13309
- DebingYMoradpourDNeytsJGouttenoireJUpdate on hepatitis E virology. Implications for clinical practiceJ. Hepatol.20166520021210.1016/j.jhep.2016.02.045
- HorvatitsTet al.Hepatitis E seroprevalence in the Americas. A systematic review and meta-analysisLiver Int.2018381951196410.1111/liv.13859
- HartlJohannesOttoBenjaminMaddenRichieWebbGlynnWoolsonKathyKristonLeventeVettorazziEikLohseAnsgarDaltonHarryPischkeSvenHepatitis E Seroprevalence in Europe: A Meta-AnalysisViruses201688211499757310.3390/v8080211
- SmithDBet al.Proposed reference sequences for hepatitis E virus subtypesJ. Gen. Virol.201697537542558889310.1099/jgv.0.000393
- DebingYet al.A rat model for hepatitis E virusDis. Models Mech.201691203121010.1242/dmm.024406
- CaoDet al.Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicityProc. Natl Acad. Sci. USA20171146914692310.1073/pnas.1705446114
- YinXAmbardekarCLuYFengZDistinct entry mechanisms for nonenveloped and quasi-enveloped hepatitis E virusesJ. Virol.20169042324242481053110.1128/JVI.02804-15
- Nagashima, S. et al. Characterization of the quasi-enveloped hepatitis E virus particles released by the cellular exosomal pathway. J. Virol.91, pii: e00822–17 (2017).
- BalayanMSet al.Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral routeIntervirology198320233110.1159/0001493706409836
- TakahashiMet al.Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in fecesArch. Virol.20081531703171310.1007/s00705-008-0179-618679765
- Chapuy-RegaudSet al.Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune responseBiochimie2017141707910.1016/j.biochi.2017.05.00328483690
- HeSet al.Putative receptor-binding sites of hepatitis E virusJ. Gen. Virol.20088924524910.1099/vir.0.83308-018089748
- HollaPAhmadIAhmedZJameelSHepatitis E virus enters liver cells through a dynamin-2, clathrin and membrane cholesterol-dependent pathwayTraffic20151639841610.1111/tra.1226025615268
- KaliaMChandraVRahmanSASehgalDJameelSHeparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infectionJ. Virol.2009831271412724278684310.1128/JVI.00717-09
- ZhangLet al.Asialoglycoprotein receptor facilitates infection of PLC/PRF/5 cells by HEV through interaction with ORF2J. Med. Virol.2016882186219510.1002/jmv.2457027155063
- TianYet al.Systematic identification of hepatitis E virus ORF2 interactome reveals that TMEM134 engages in ORF2-mediated NF-κB pathwayVirus Res.201722810210810.1016/j.virusres.2016.11.02727899274
- YuHet al.Homology model and potential virus-capsid binding site of a putative HEV receptor Grp78J. Mol. Model.20111798799510.1007/s00894-010-0794-520628775
- ZhengZZet al.Role of heat-shock protein 90 in hepatitis E virus capsid traffickingJ. Gen. Virol.2010911728173610.1099/vir.0.019323-020219895
- TsarevSAet al.Characterization of a prototype strain of hepatitis E virusProc. Natl Acad. Sci. USA19928955956310.1073/pnas.89.2.5591731327
- GraffJTorianUNguyenHEmersonSUA bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virusJ. Virol.20068059195926147255910.1128/JVI.00046-06
- MagdenJet al.Virus-specific mRNA capping enzyme encoded by hepatitis E virusJ. Virol.2001756249625511434610.1128/JVI.75.14.6249-6255.2001
- SehgalDThomasSChakrabortyMJameelSExpression and processing of the hepatitis E virus ORF1 nonstructural polyproteinVirol. J.20063148163410.1186/1743-422X-3-38
- Kanade, G. D., Pingale, K. D. & Karpe, Y. A. Activities of thrombin andfactor Xa are essential for replication of hepatitis E virus and are possibly implicated in ORF1 polyprotein processing. J. Virol.92, pii: e01853–17 (2018).
- KarpeYALoleKSNTPase and 5’ to 3’ RNA duplex-unwinding activities of the hepatitis E virus helicase domainJ. Virol.20108435953602283809310.1128/JVI.02130-09
- MahilkarSPaingankarMSLoleKSHepatitis E virus RNA-dependent RNA polymerase. RNA template specificities, recruitment and synthesisJ. Gen. Virol.2016972231224210.1099/jgv.0.00052827324050
- OstermanAet al.The hepatitis E virus intraviral interactomeSci. Rep.20155460445710.1038/srep13872
- Todt, D., Walter, S., Brown, R. J. P. & Steinmann, E. Mutagenic effects of ribavirin on hepatitis E virus-viral extinction versus selection of fitness-enhancing mutations. Viruses8, pii: E283 (2016).
- Haldipur, B., Bhukya, P. L., Arankalle, V. & Lole, K. Positive regulation of hepatitis E virus replication by microRNA-122. J. Virol.92, pii: e01999–17 (2018).
- Kaushik, N. et al. Zinc salts block hepatitis E virus replication by inhibiting the activity of viral RNA-dependent RNA polymerase. J. Virol.91, pii: e00754–17 (2017).
- GraffJet al.The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaquesJ. Virol.20057966806689111213410.1128/JVI.79.11.6680-6689.2005
- HuangYWOpriessnigTHalburPGMengXJInitiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivoJ. Virol.20078130183026186601010.1128/JVI.02259-06
- TyagiSKorkayaHZafrullahMJameelSLalSKThe phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2J. Biol. Chem.2002277227592276710.1074/jbc.M200185200
- TyagiSSurjitMRoyAKJameelSLalSKThe ORF3 protein of hepatitis E virus interacts with liver-specific alpha1-microglobulin and its precursor alpha1-microglobulin/bikunin precursor (AMBP) and expedites their export from the hepatocyteJ. Biol. Chem.2004279293082931910.1074/jbc.M402017200
- EmersonSUNguyenHTorianUPurcellRHORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitroJ. Virol.2006801045710464164177410.1128/JVI.00892-06
- DingQet al.Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particlesProc. Natl Acad. Sci. USA20171141147115210.1073/pnas.161495511428096411
- KenneySPet al.The PSAP motif within the ORF3 protein of an avian strain of the hepatitis E virus is not critical for viral infectivity in vivo but plays a role in virus releaseJ. Virol.20128656375646334729910.1128/JVI.06711-11
- SurjitMOberoiRKumarRLalSKEnhanced alpha1 microglobulin secretion from hepatitis E virus ORF3-expressing human hepatoma cells is mediated by the tumor susceptibility gene 101J. Biol. Chem.20062818135814210.1074/jbc.M50956820016407257
- YamadaKet al.Construction of an infectious cDNA clone of hepatitis E virus strain JE03-1760F that can propagate efficiently in cultured cellsJ. Gen. Virol.20099045746210.1099/vir.0.007559-019141456
- NagashimaSet al.Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virionsJ. Gen. Virol.2011922838284810.1099/vir.0.035378-021880841
- NagashimaSet al.The membrane on the surface of hepatitis E virus particles is derived from the intracellular membrane and contains trans-Golgi network protein 2Arch. Virol.201415997999110.1007/s00705-013-1912-324221250
- Anang, S. et al. Potent inhibition of hepatitis E virus release by a cyclic peptide inhibitor of the interaction between viral open reading frame 3 protein and host tumor susceptibility gene 101. J. Virol.92, pii: e00684–18 (2018).
- KorkayaHet al.The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPKJ. Biol. Chem.2001276423894240010.1074/jbc.M10154620011518702
- TyagiSSurjitMLalSKThe 41-amino-acid C-terminal region of the hepatitis E virus ORF3 protein interacts with bikunin, a kunitz-type serine protease inhibitorJ. Virol.2005791208112087121258810.1128/JVI.79.18.12081-12087.2005
- HuangRet al.Hepatitis E virus (87A strain) propagated in A549 cellsJ. Med. Virol.19954729930210.1002/jmv.18904704028636694
- MengXJet al.A novel virus in swine is closely related to the human hepatitis E virusProc. Natl Acad. Sci. USA1997949860986510.1073/pnas.94.18.98609275216
- WangYouchunLingRogerZhangHuayuanLiHeminHarrisonTim J.The complete sequence of hepatitis E virus genotype 4 reveals an alternative strategy for translation of open reading frames 2 and 3Journal of General Virology20008171675168610.1099/0022-1317-81-7-167510859372
- LuLLiCHagedornCHPhylogenetic analysis of global hepatitis E virus sequences. Genetic diversity, subtypes and zoonosisRev. Med. Virol.20061653610.1002/rmv.48216175650
- HaqshenasG.ReadD. H.WoolcockP. R.ShivaprasadH. L.MengX. J.Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis–splenomegaly syndrome in the United StatesJournal of General Virology200182102449246210.1099/0022-1317-82-10-244911562538
- TeiSKitajimaNTakahashiKMishiroSZoonotic transmission of hepatitis E virus from deer to human beingsLancet200336237137310.1016/S0140-6736(03)14025-112907011
- SunZFet al.Genetic identification of avian hepatitis E virus (HEV) from healthy chicken flocks and characterization of the capsid gene of 14 avian HEV isolates from chickens with hepatitis-splenomegaly syndrome in different geographical regions of the United StatesJ. Gen. Virol.20048569370010.1099/vir.0.19582-014993655
- Doceul, V., Bagdassarian, E., Demange, A. & Pavio, N. Zoonotic hepatitis E virus. Classification, animal reservoirs and transmission routes. Viruses8, pii: E270 (2016).
- TamAWet al.In vitro propagation and production of hepatitis E virus from in vivo-infected primary macaque hepatocytesVirology19962151910.1006/viro.1996.00018553579
- PandaSKAnsariIHDurgapalHAgrawalSJameelSThe in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is IifectiousJ. Virol.2000742430243711172610.1128/JVI.74.5.2430-2437.2000
- EmersonS. U.ZhangM.MengX.- J.NguyenH.St. ClaireM.GovindarajanS.HuangY. K.PurcellR. H.Recombinant hepatitis E virus genomes infectious for primates: Importance of capping and discovery of a cis-reactive elementProceedings of the National Academy of Sciences20019826152701527510.1073/pnas.251555098
- EmersonSUet al.In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent proteinJ. Virol.2004784838484638767610.1128/JVI.78.9.4838-4846.2004
- PudupakamRSet al.Mutational analysis of the hypervariable region of hepatitis e virus reveals its involvement in the efficiency of viral RNA replicationJ. Virol.2011851003110040319638610.1128/JVI.00763-11
- ShuklaPet al.Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombinationJ. Virol.20128656975707334731210.1128/JVI.00146-12
- TanakaTet al.Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patientJ. Clin. Microbiol.20094719061910269109010.1128/JCM.00629-09
- InoueJ.Analysis of human and swine hepatitis E virus (HEV) isolates of genotype 3 in Japan that are only 81-83 % similar to reported HEV isolates of the same genotype over the entire genomeJournal of General Virology20068782363236910.1099/vir.0.81912-016847132
- ShuklaPet al.Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinantProc. Natl Acad. Sci. USA20111082438244310.1073/pnas.101887810821262830
- NguyenHTet al.A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell cultureJ. Gen. Virol.201293526530335235210.1099/vir.0.037259-0
- Schemmerer, M. et al. Enhanced replication of hepatitis E virus strain 47832c in an A549-derived subclonal cell line. Viruses8, pii: E267 (2016).
- JohneRet al.An ORF1-rearranged hepatitis E virus derived from a chronically infected patient efficiently replicates in cell cultureJ. Viral Hepat.20142144745610.1111/jvh.1215724750215
- SmithDBet al.Evolution of the hepatitis E virus hypervariable regionJ. General. Virol.2012932408241810.1099/vir.0.045351-0
- Dao Thi, V. L., Wu, X. & Rice, C. M. Stem cell-derived culture models of hepatitis E virus infection. Cold Spring Harbor Perspect. Med. pii: a031799 (2018). 10.1101/cshperspect.a031799.
- PurcellR. H.EmersonS. U.Animal Models of Hepatitis A and EILAR Journal200142216117710.1093/ilar.42.2.16111406718
- TsarevSAet al.ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primatesJ. Infect. Dis.199316836937810.1093/infdis/168.2.369
- TSAREVSRecombinant vaccine against hepatitis E: dose response and protection against heterologous challengeVaccine19971517-181834183810.1016/S0264-410X(97)00145-X
- SalinesMAndraudMRoseNFrom the epidemiology of hepatitis E virus (HEV) within the swine reservoir to public health risk mitigation strategies: a comprehensive reviewVet. Res.201748544543910.1186/s13567-017-0436-3
- SanfordBJet al.Prior infection of pigs with a genotype 3 swine hepatitis E virus (HEV) protects against subsequent challenges with homologous and heterologous genotypes 3 and 4 human HEVVirus Res.20111591722310612810.1016/j.virusres.2011.04.010
- CossaboomCMCórdobaLDrymanBAMengXJHepatitis E virus in rabbits, Virginia, USAEmerg. Infect. Dis.20111720472049331056510.3201/eid1711.110428
- IzopetJet al.Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, FranceEmerg. Infect. Dis.20121812741281341403610.3201/eid1808.120057
- Li, T.-C. & Wakita, T. Small animal models of hepatitis E virus infection. Cold Spring Harb. Perspect. Med. pii: a032581 (2018). 10.1101/cshperspect.a032581
- Kabrane-LaziziYet al.Evidence for widespread infection of wild rats with hepatitis E virus in the United StatesAm. J. Trop. Med. Hyg.19996133133510.4269/ajtmh.1999.61.33110463689
- JohneRet al.Novel hepatitis E virus genotype in Norway rats, GermanyEmerg. Infect. Dis.20101614521455329498510.3201/eid1609.100444
- ZhangHangAdvances in Animal Models of Hepatitis B Virus InfectionInfection International2015449610110.1515/ii-2017-0115
- YuWet al.Characterization of hepatitis E virus infection in tree shrew (Tupaia belangeri chinensis)BMC Infect. Dis.201616475499910.1186/s12879-016-1418-1
- García-Bocanegra, I. et al. Hepatitis E virus infection in equines in Spain. Transbound. Emerg. Dis. (2018).
- XingLet al.Recombinant hepatitis E capsid protein self-assembles into a dual-domain T=1 particle presenting native virus epitopesVirology1999265354510.1006/viro.1999.0005
- He, J., Ching, W. M., Yarbough, P., Wang, H. & Carl, M. Purification of baculovirus-expressed hepatitis E virus structural protein and utility in an enzyme-linked immunosorbent assay. J. Clin. Microbiol.33, 3308–3311 (1995).
- Zhang, Y., Mcatee, P., Yarbough, P. O., Tam, A. W. & Fuerst, T. Clinical Diagnostic LaboratoryImmunology., 4, 423–428 (1997).
- RobinsonRAet al.Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cellsProtein Expr. Purif.199812758410.1006/prep.1997.0817
- YamashitaTet al.Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structureProc. Natl Acad. Sci. USA2009106129861299110.1073/pnas.0903699106
- GuuT. S. Y.LiuZ.YeQ.MataD. A.LiK.YinC.ZhangJ.TaoY. J.Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor bindingProceedings of the National Academy of Sciences200910631129921299710.1073/pnas.0904848106
- LiSWet al.A bacterially expressed particulate hepatitis E vaccine. Antigenicity, immunogenicity and protectivity on primatesVaccine2005232893290110.1016/j.vaccine.2004.11.064
- TakahashiMet al.Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies. Characterization of HEV virions in blood circulationJ. Clin. Microbiol.20104811121125284959910.1128/JCM.02002-09
- EmersonSUet al.Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motifJ. Virol.20108490599069293762910.1128/JVI.00593-10
- LiSWet al.The development of a recombinant hepatitis E vaccine HEV 239Hum. Vaccine Immunother.20151190891410.1080/21645515.2015.1008870
- TorresiJet al.High level expression of the capsid protein of hepatitis E virus in diverse eukaryotic cells using the Semliki Forest virus repliconJ. Virol. Methods199769819110.1016/S0166-0934(97)00142-09504754
- GraffJet al.Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particlesJ. Virol.2008821185119410.1128/JVI.01219-0718032496
- MontpellierCet al.Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid ProteinGastroenterology2018154211223.e810.1053/j.gastro.2017.09.02028958858
- TorresiJLocarniniS AAndersonD ALiFOnly the non-glycosylated fraction of hepatitis E virus capsid (open reading frame 2) protein is stable in mammalian cellsJournal of General Virology19998051185118810.1099/0022-1317-80-5-118510355765
- ZhangJet al.Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid proteinVaccine2005232881289210.1016/j.vaccine.2004.11.06515780737
- ZhaoMet al.A Comprehensive study of neutralizing antigenic sites on the hepatitis E virus (HEV) capsid by constructing, clustering, and characterizing a tool boxJ. Biol. Chem.20152901991019922452815010.1074/jbc.M115.649764
- TsarevSAet al.Successful passive and active immunization of cynomolgus monkeys against hepatitis EProc. Nati. Acad. Sci. USA19941994101981020210.1073/pnas.91.21.10198
- PurcellRHet al.Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccineVaccine2003212607261510.1016/S0264-410X(03)00100-212744897
- TangXet al.Structural basis for the neutralization and genotype specificity of hepatitis E virusProc. Natl Acad. Sci. USA2011108102661027110.1073/pnas.110130910821642534
- MakarGASafety and efficacy of a recombinant hepatitis E vaccineYearbook Gastroenterol.2007247248
- LiSWet al.Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsidJ. Biol. Chem.20052803400340610.1074/jbc.M41036120015557331
- WeiMet al.Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopesVaccine2014322859286510.1016/j.vaccine.2014.02.02524662711
- ZhangJet al.Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccineVaccine2009271869187410.1016/j.vaccine.2008.12.06119168109
- ZhuFCet al.Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults. A large-scale, randomised, double-blind placebo-controlled, phase 3 trialLancet201037689590210.1016/S0140-6736(10)61030-620728932
- ZhangJet al.Long-term efficacy of a hepatitis E vaccineN. Engl. J. Med.201537291492210.1056/NEJMoa140601125738667
- CaoYFet al.A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccineVaccine2017355073508010.1016/j.vaccine.2017.05.07228803715
- HoadVCet al.Hepatitis E virus RNA in Australian blood donors. Prevalence and risk assessmentVox Sang.201711261462110.1111/vox.1255928833229
- HogemaBMet al.Incidence and duration of hepatitis E virus infection in Dutch blood donorsTransfusion20165672272810.1111/trf.1340226559806
- HewittPEet al.Hepatitis E virus in blood components. A prevalence and transmission study in southeast EnglandLancet20143841766177310.1016/S0140-6736(14)61034-5
- KhurooMSKamiliSYattooGNHepatitis E virus infection may be transmitted through blood transfusions in an endemic areaJ. Gastroenterol. Hepatol.20041977878410.1111/j.1440-1746.2004.03437.x15209625
- Domanović, D. et al. Hepatitis E and blood donation safety in selected European countries. A shift to screening? Euro Surveill.22, pii: 30514 (2017).
- DreierJKnabbeCVollmerTTransfusion-transmitted hepatitis E: NAT screening of blood donations and infectious doseFront. Med.20185510.3389/fmed.2018.00005